Body Weight Management in Healthy Humans Using Low-Sugar and High-Dietary Fiber Noodles : A Single Group Pre-Post Trial

Author:

Kadokura Kazunari1,Tomita Tsuyoshi1,Toyama Haruki2,Ohnuki Koichiro2,Suruga Kohei1ORCID

Affiliation:

1. Research & Development Division, Products Development Department, Kibun Foods Inc., 86 Yanokuchi, Inagi, Tokyo 2060812, Japan

2. Department of Biological and Environmental Chemistry, Kinki University Kyushu, Kayanomori, Izuka, Fukuoka 8208555, Japan

Abstract

Background. The recommendation of the low-carbohydrate diet by the American Diabetes Association (2013) has popularized its use as a nutritional treatment. Previously, we evaluated the effects of a novel strategy to reduce dietary intake based on low-sugar, high-dietary fiber noodles (LS-HDFNs) composed of okara and konjac on blood glucose levels in healthy animals, animal models of type 2 diabetes, and healthy humans (the single meal test). In this study, a single group pre-post trial for 28 days administration was carried out to investigate the body weight management in healthy humans using LS-HDFNs. Methods. Nine healthy subjects were requested to eat LS-HDFNs once (180 g) daily for 28 days. Physical characteristics and blood biochemical parameters were measured before (0 day) and after (28 days) the consumption of the noodles. Qualitative analysis of compounds in the noodles was investigated by the HPLC system and the UPLC/qTOF-MS system. Results. The LS-HDFNs group did not exhibit any complications or adverse effects. Furthermore, the body weights, body fat percentage, total cholesterol, and low-density lipoprotein cholesterol were significantly reduced after 28 days of LS-HDFNs consumption. Some isoflavones, amino acids, peptides, and phospholipids were contained in the LS-HDFNs. Conclusion. As per our knowledge, this is the first study of the usefulness of consumption of LS-HDFNs for 28 days for body weight management in healthy humans. LS-HDFNs may be useful for body weight management. This trial is registered with number 2020002, registered on 2nd March 2020.

Publisher

Hindawi Limited

Subject

Cell Biology,Pharmacology,Food Science,Biophysics

Reference44 articles.

1. Noncommunicable diseases;World Health Organization,2022

2. Obesity and overweight;World Health Organization,2020

3. Systems and WBANs for Controlling Obesity

4. Standards of Medical Care in Diabetes—2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3